The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats

Alfasan Nederland B.VVPA10980/020/001

Main Information

Trade NameXylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats
Active SubstancesXylazine Hydrochloride
Dosage FormSolution for injection
Licence HolderAlfasan Nederland B.V
License Holder AddressKuipersweg 9
3449 JA Woerden
Licence NumberVPA10980/020/001

Group Information

ATC CodeQN05CM92 xylazine
Therapeutic ClassNeurological Preparations


License statusAuthorised
Licence Issued07/10/2022
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back